Fisher Asset Management LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 749.5% in the 3rd quarter, Holdings Channel.com reports. The firm owned 61,623 shares of the company’s stock after acquiring an additional 54,369 shares during the period. Fisher Asset Management LLC’s holdings in Colgate-Palmolive were worth $6,397,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in CL. Gordian Advisors LLC purchased a new position in Colgate-Palmolive in the 3rd quarter worth approximately $602,000. Carrera Capital Advisors raised its holdings in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Vontobel Holding Ltd. raised its holdings in Colgate-Palmolive by 224.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after acquiring an additional 550,750 shares during the last quarter. PGGM Investments raised its holdings in Colgate-Palmolive by 171.8% in the 2nd quarter. PGGM Investments now owns 157,608 shares of the company’s stock worth $15,294,000 after acquiring an additional 99,624 shares during the last quarter. Finally, QRG Capital Management Inc. raised its holdings in Colgate-Palmolive by 11.2% in the 2nd quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock worth $5,558,000 after acquiring an additional 5,751 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.37% of the stock is currently owned by company insiders.
Colgate-Palmolive Trading Up 0.2 %
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s payout ratio is presently 57.31%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on CL shares. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $105.00 to $101.00 in a report on Monday, October 28th. Piper Sandler started coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price for the company. Finally, Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $105.11.
View Our Latest Research Report on CL
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- The 3 Best Fintech Stocks to Buy Now
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Learn Technical Analysis Skills to Master the Stock Market
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.